News

The show travels to Curitiba, Brazil to see how Tissue Regenix unique dCELL^® technology is transforming the lives of heart valve patients, with over 1,600 operations now undertaken. ‘Innovations’ will hear from both the patients who have received the dCELL^® valves, and Dr Francisco da Costa who is pioneering the treatment in Curitiba, where dCELL^® valves have now set the benchmark for treatment.

Antony Odell, CEO Tissue Regenix Group commented: “We are very proud of the cardiac research work that has been undertaken in Brazil over the last 10 years. Innovations is an opportunity for us to showcase the life changing potential of our cutting edge dCELL^® technology, particularly the heart valves”

dCELL^® technology is a gentle process which removes DNA and cellular material from donor tissues. This leaves intact an acellular matrix upon which the patient’s own cells can repopulate, regenerating native tissue which will not be rejected by the body.

Tissue Regenix has applied dCELL^® technology to wound care, orthopaedic sports medicine and cardiac applications, it is expected that the first dCELL^® heart valves will also be available in Europe during 2017.

Innovations w/Ed Begley, Jr – INTV0721 (Science & Technology VII) from DMG Productions on Vimeo.

About Tissue Regenix

Tissue Regenix is a leading medical devices company in the field of regenerative medicine. The company’s patented decellularisation (‘dCELL^®‘) technology removes DNA and other cellular material from animal and human tissue leaving an acellular tissue scaffold which is not rejected by the patient’s body which can then be used to repair diseased or worn out body parts. The potential applications of this process are diverse and address many critical clinical needs such as vascular disease, heart valve replacement and knee repair.

Tissue Regenix was formed in 2006 when it was spun-out from the University of Leeds. The company commercialises academic research conducted by our partners around the World.

In November 2012 Tissue Regenix Group plc set up a subsidiary company in the United States – ‘Tissue Regenix Wound Care Inc.’, as part of its commercialisation strategy for its dCELL^® technology platform.

About Innovations & DMG Productions:

Innovations, hosted by award winning actor Ed Begley, Jr., is an information-based series geared toward educating the public on the latest breakthroughs in all areas of society. Featuring practical solutions and important issues facing consumers and professionals alike, Innovations focuses on cutting-edge advancements in everything from health and wellness to global business, renewable energy, and more.